6-KThe Wire
Telix Pharmaceuticals Ltd files 6-K
Filed Apr 14, 2026 · 2mo ago · Accession 0001140361-26-014495
Plain English
Telix Pharmaceuticals Limited announced the refinancing of its convertible bonds on April 14, 2026. This report contains exhibits related to this announcement and an investor presentation.
Filing details
- Company
- Telix Pharmaceuticals Ltd
- Ticker
- TLX
- CIK
- 2007191
- Form type
- 6-K
- Filing date
- Apr 14, 2026
- Report date
- Apr 14, 2026
- Document
- ef20070387_6k.htm
- Size
- 3.8 MB
More from TLX
6-KThe WireJul 2, 20266-KCURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTSMay 21, 20266-KCURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTSApr 23, 20266-KCURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTSApr 21, 20266-KCURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTSApr 20, 20266-KThe WireApr 14, 2026